Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREAs an aid in the prevention of reovirus induced tenosynovitis by spray or drinking water administration.
LEARN MORE